Background and aim: Creating potential clinical markers for risk assessment in patients with COVID-19 continues to be an area of interest. In this study, we aimed to evaluate whether serum albumin level and thrombocyte/lymphocyte ratio are related to the severity of the disease. Materials and methods: The patients were divided into two groups according to the severity of disease. Demographic data, serum albumin value, lymphocyte count, TLO-1 values (thrombocyte/lymphocyte ratio-1), the highest thrombocyte count during hospitalization, TLO-2 (thrombocyte/lymphocyte ratio-2) values formed by the highest thrombocyte count, were recorded. Results: There was no statistically significant differences (P > 0.05) in terms of sex, thrombocyte count at the time of admission, and highest thrombocyte count during hospital follow-up. There were statistically significant differences in terms of age, comorbidity, lymphocyte value at the time of hospitalization, lymphocyte count during hospital follow-up, TLO 1, TLO 2, and serum albumin values between the groups. The ICU group were found to be older, had higher rates of comorbidity, lower lymphocyte values, higher TLO 1-2, and lower serum albumin levels (P < 0.05). Conclusion: TLO-2 ratio above 260 and lymphocyte level below 1 103 cells/µL, would be a predictor of further intensive care unit need.
Severity of COVID 19, platelet lenfosit ratio, serum albumin value
UYAR, EMEL; MERDİN, ALPARSLAN; YAMANYAR, SERDAR; EZGÜ, MEHMET CAN; ARTUK, CUMHUR; TAŞKIN, GÜRHAN; ARSLAN, YAKUP; and CERİTLİ, SERKAN
"Could serum albumin value and thrombocyte/lymphocyte ratio be an importantprognostic factor in determining the severity of COVID 19?,"
Turkish Journal of Medical Sciences: Vol. 51:
3, Article 7.
Available at: https://journals.tubitak.gov.tr/medical/vol51/iss3/7